Antibiotic 899,
Eskalin,
Founderguard,
Stajac,
Staphylomycin,
Virgimycine,
Virginiamycin,
Virginiamycin,
11006-76-1,
BCP19339,
Pristinamycin,
Ostreogricina,
Ostreogrycine,
Ostreogrycinum,
Pristinamicina,
Pristinamycine,
Pristinamycinum,
Staphylomycin,
Streptogramin,
Virginiamicina,
Virginiamycina,
Virginiamycine,
Virginiamycinum,
Micamicina,
Mikamycine,
Mikamycinum,
Ostreogrycin,
Pyostacine,
Stapyocine,
Vernamycin,
Virgimycin,
Mikamycin,
Patricin,
Stafac,
Eskalin V,
Stafac 20,
Stafac 50,
Virginiamycin Complex,
Eskalin 500,
Virginiamycin (USAN,
Stafac 500,
Antibiotic No. 899,
Mikamycine [INN-French],
Mikamycinum [INN-Latin],
Micamicina [INN-Spanish],
Ostreogrycine [INN-French],
Ostreogrycinum [INN-Latin],
Mikamycin [BAN:DCF:INN],
UNII-C49WS9N75L,
Ostreogricina [INN-Spanish],
Pristinamycine [INN-French],
Pristinamycinum [INN-Latin],
Virginiamycine [INN-French],
Virginiamycinum [INN-Latin],
Pristinamicina [INN-Spanish],
Virginiamicina [INN-Spanish],
Virginiamycina [INN-Spanish],
V-MAX 50,
Virginiamycin [USAN:INN:BAN],
HSDB 7033,
SKF 7988,
EINECS 234-244-6,
RP7293,
Pristinamycin;Staphylomycin;Mikamycine;RP 7293;RP-7293;RP7293;Pyostacine,
A mixture of two principal antibiotic components, virginiamycin M1 (Factor M1) and virginiamycin S1 (Factor S). Virginiamycin,
N-(3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl)-3-hydroxypyridine-2-carboxamide;(12Z,17Z,19Z)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone,